Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–5 of 5 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Not Yet Recruiting
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
NCT07691450
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +36 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04774068
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
NCT03534180
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
NCT02520791
- Conditions
- Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, Not Recruiting
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
NCT02978625
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States